# Treg Cell Therapy in Liver and Kidney Transplantation - Preclinical Validation of Batches of Treg Cells Amplified in Vitro

> **NCT04661254** · NA · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 4 (estimated)

## Conditions studied

- Kidney Transplantation
- Liver Transplantation

## Interventions

- **OTHER:** Lymphapheresis

## Key facts

- **NCT ID:** NCT04661254
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-15
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 4 (ESTIMATED)
- **Last updated:** 2023-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04661254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04661254, "Treg Cell Therapy in Liver and Kidney Transplantation - Preclinical Validation of Batches of Treg Cells Amplified in Vitro". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT04661254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*